Publicaciones en las que colabora con CELSO ARANGO LÓPEZ (61)

2024

  1. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. Impact of the COVID-19 pandemic on the mental health of the general population and health care workers

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 125-143

  3. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis

    British Journal of Psychiatry, Vol. 31, Núm. 2

  4. Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism

    Journal of Autism and Developmental Disorders, Vol. 53, Núm. 1, pp. 66-79

  5. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 62, Núm. 2, pp. 151-168

  6. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149

  7. The impact of COVID-19 lockdown on child and adolescent mental health: systematic review

    European Child and Adolescent Psychiatry, Vol. 32, Núm. 7, pp. 1151-1177

  8. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

2022

  1. Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale

    European Child and Adolescent Psychiatry, Vol. 31, Núm. 11, pp. 1715-1728

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Annual Research Review: Prevention of psychosis in adolescents – systematic review and meta-analysis of advances in detection, prognosis and intervention

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 62, Núm. 5, pp. 657-673

  2. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis

    EClinicalMedicine, Vol. 36

  3. Patient care, right to information and consent for minors in situations of parental conflict. Clinical guidelines in the context of Spanish legislation

    Anales de Pediatria, Vol. 94, Núm. 5, pp. 338.e1-338.e7

  4. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63

2020

  1. DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders

    Frontiers in Psychiatry, Vol. 11

  2. Demographic and Clinical Characteristics, including Subsyndromal Symptoms across Bipolar-Spectrum Disorders in Adolescents

    Journal of Child and Adolescent Psychopharmacology, Vol. 30, Núm. 4, pp. 222-234

  3. How mental health care should change as a consequence of the COVID-19 pandemic

    The Lancet Psychiatry, Vol. 7, Núm. 9, pp. 813-824

  4. Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis

    Journal of Affective Disorders, Vol. 275, pp. 48-57

  5. Mental health care and COVID-19

    The Lancet Psychiatry